Skip to main content

Hypercoagulable State Associated With COVID-19 Infection

Date: Thursday, Nov 12, 2020


  • Identify key coagulation markers that are associated with increasedmortality in COVID-19 infected patients
  • Distinguish COVID-19 hypercoagulability from other hypercoagulable states
  • Understand key laboratory issues associated with thrombophilia testing and anticoagulant monitoring in patients with COVID-19 infection


Racke, Frederick K., MD, PhD.
Medical Director, Hematology/Oncology and Coagulation,
Nichols Institute
Quest Diagnostics
San Juan Capistrano, CA

Wong, Edward C. C., MD
Medical Director, Quest Diagnostics; Adj Assoc Professor, George Washington School of Medicine and Health Sciences; Clinical Consultant, Children’s National Hospital